Resmed Inc. [RMD] stock is trading at $242.25, up 7.26%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RMD shares have gain 8.56% over the last week, with a monthly amount glided 16.16%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Resmed Inc. [NYSE: RMD] stock has seen the most recent analyst activity on June 25, 2024, when Oppenheimer downgraded its rating to a Perform. Previously, Citigroup downgraded its rating to Neutral on June 24, 2024. Morgan Stanley upgraded its rating to a Overweight and decreased its price target to $169 on October 27, 2023. RBC Capital Mkts downgraded its rating to a Sector Perform and reduced its price target to $202 on October 12, 2023. JP Morgan upgraded its rating to Overweight for this stock on October 09, 2023, and downed its price target to $170. In a note dated September 29, 2023, Wolfe Research downgraded an Peer Perform rating on this stock.
Resmed Inc. [RMD] stock has fluctuated between $132.24 and $231.50 over the past year. Currently, Wall Street analysts expect the stock to reach $209.33 within the next 12 months. Resmed Inc. [NYSE: RMD] shares were valued at $242.25 at the most recent close of the market. An investor can expect a potential drop of -13.59% based on the average RMD price forecast.
Analyzing the RMD fundamentals
Resmed Inc. [NYSE:RMD] reported sales of 4.69B for the trailing twelve months, which represents a growth of 9.01%. Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at 0.29%, Pretax Profit Margin comes in at 0.28%, and Net Profit Margin reading is 0.22%. To continue investigating profitability, this company’s Return on Assets is posted at 0.15, Equity is 0.22 and Total Capital is 0.22. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 231.39 points at the first support level, and at 220.54 for the second support level. However, for the 1st resistance point, the stock is sitting at 247.85, and for the 2nd resistance point, it is at 253.46.
Ratios To Look Out For
For context, Resmed Inc.’s Current Ratio is 2.59. In addition, the Quick Ratio stands at 1.69 and the Cash Ratio stands at 0.26. Considering the valuation of this stock, the price to sales ratio is 7.60, the price to book ratio is 7.32 and price to earnings (TTM) ratio is 35.00.
Transactions by insiders
Recent insider trading involved Rider Michael J, Global General Counsel, that happened on Aug 20 ’24 when 882.0 shares were sold. Officer, Rider Michael J completed a deal on Aug 20 ’24 to buy 883.0 shares. Meanwhile, President, SaaS Business Ghoshal Kaushik sold 10000.0 shares on Aug 12 ’24.
